Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Hybrigenics SA 

180 Avenue Daumesnil

Paris    F-75012  France
Phone: 33-1-70-91-29-00 Fax: 33-1-70-91-29-49


 Company News
Hybrigenics Starts Phase II Clinical Trial of Inecalcitol in Chronic Lymphocytic Leukemia 9/11/2012 11:00:28 AM
Bryan, Garnier & Co Initiates Coverage of Hybrigenics with a Target Price of €2.6 3/29/2012 6:56:24 AM
Hybrigenics' Specific Inhibitor of Ubiquitin-Specific Protease 7 (USP7) is Cytotoxic for Chronic Lymphocytic Leukaemia (CLL) Cells in Vitro 10/28/2011 10:33:53 AM
Hybrigenics 2011 First-Half Results 10/18/2011 11:02:59 AM
Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields 10/10/2011 9:49:14 AM
Hybrigenics Appoints Dr Alain Munoz to its Board of Directors 10/5/2011 10:55:57 AM
Hybrigenics Gets Approval and Funding for a Phase II Clinical Trial of Inecalcitol in Psoriasis 9/6/2011 11:27:12 AM
Hybrigenics Maintains Stable EUR Two Million Revenues in First Half of 2011 8/23/2011 10:00:15 AM
Hybrigenics' Inecalcitol Inhibits the Growth of Human Hormone-Dependent Prostate Cancer Cells in Vitro and in Vivo 7/12/2011 9:23:23 AM
Hybrigenics to Present Inecalcitol Results at the Annual Meeting of the American Society of Clinical Oncology 6/1/2011 8:46:52 AM